ABEO

Abeona Therapeutics Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$2.29

Price (1 Year)

$7.24 $2.29

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %4.8 / %30
Non-compliant assets / Total market cap %54 / %30
Non-compliant revenue / Total income %12.9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.

Website

Analysis (Turkish): ABEO Hissesi Caiz mi, Helal mi? Abeona Therapeutics Inc. Katılım Analizi